Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

British representatives to international parliamentary assemblies: 1949-1970

Autor: Zakheim, D

For over twenty years, beginning in 1949, more than a score of British Members of Parliament, and an additional handful of Peers, have absented themselves from Westminster for up to two months of the Parliamentary session with the approval, indeed up

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1064::6621c022907627249ccdd525a863bdb8
https://ora.ox.ac.uk/objects/uuid:b50d26fd-0ad4-441a-a846-830b9ed4375e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition.

Autor: Inoue D; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Polaski JT; Public Health Sciences and Basic Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Taylor J; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA., Castel P; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Chen S; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Kobayashi S; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.; Division of Cellular Therapy, The Institute of Medical Science, the University of Tokyo, Tokyo, Japan., Hogg SJ; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Hayashi Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan., Pineda JMB; Public Health Sciences and Basic Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA.; Medical Scientist Training Program, University of Washington, Seattle, WA, USA., El Marabti E; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Erickson C; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Knorr K; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Fukumoto M; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan., Yamazaki H; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan., Tanaka A; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.; Department of Immunology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan., Fukui C; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan., Lu SX; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Durham BH; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Liu B; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Wang E; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Mehta S; Gene Editing & Screening Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zakheim D; Gene Editing & Screening Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Garippa R; Gene Editing & Screening Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Penson A; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA., Chew GL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., McCormick F; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Bradley RK; Public Health Sciences and Basic Sciences Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rbradley@fredhutch.org.; Department of Genome Sciences, University of Washington, Seattle, WA, USA. rbradley@fredhutch.org., Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan KetterAbsolute numbers of live mature hematopoietic cellsing Cancer Center, New York, NY, USA. abdelwao@mskcc.org.

Publikováno v: Nature genetics [Nat Genet] 2021 May; Vol. 53 (5), pp. 707-718. Date of Electronic Publication: 2021 Apr 12.